1 results match your criteria: "Centre des Maladies Cognitives et Comportementales et Inserm U 610[Affiliation]"

Current treatments for Alzheimer's disease aim to compensate for biochemical deficits in the brain. They are purely symptomatic and restore the central cholinergic deficit. Acetylcholinesterase inhibitors have modest but significant efficacy on cognitive disorders, activities of daily living, and the global clinical impression.

View Article and Find Full Text PDF